Expandable and reversible copy number amplification drives rapid adaptation to antifungal drugs

Robert T. Todd, Anna Selmecki

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Previously, we identified long repeat sequences that are frequently associated with genome rearrangements, including copy number variation (CNV), in many diverse isolates of the human fungal pathogen Candida albicans (Todd et al., 2019). Here, we describe the rapid acquisition of novel, high copy number CNVs during adaptation to azole antifungal drugs. Single-cell karyotype analysis indicates that these CNVs appear to arise via a dicentric chromosome intermediate and breakage-fusion-bridge cycles that are repaired using multiple distinct long inverted repeat sequences. Subsequent removal of the antifungal drug can lead to a dramatic loss of the CNV and reversion to the progenitor genotype and drug susceptibility phenotype. These findings support a novel mechanism for the rapid acquisition of antifungal drug resistance and provide genomic evidence for the heterogeneity frequently observed in clinical settings.

Original languageEnglish (US)
Article numbere58349
Pages (from-to)1-33
Number of pages33
JournaleLife
Volume9
DOIs
StatePublished - Jul 2020

PubMed: MeSH publication types

  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

Fingerprint Dive into the research topics of 'Expandable and reversible copy number amplification drives rapid adaptation to antifungal drugs'. Together they form a unique fingerprint.

  • Cite this